Galsulfase
Records for this ingredient, by country (identity only).
ATC A16AB08 · 8 markets · 9 records
AU 2 records · 1 shown of 1
- 5 mg per mL / per unit basis not statedinjectionNAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 5 mg/5 mLliquidNAGLAZYME
GB 1 records · 1 shown of 1
- 5 mg/5 mLinjectionNaglazyme 5mg/5ml solution for infusion vials
CA 1 records · 1 shown of 1
- 1 mg per mL / per unit basis not statedliquidNAGLAZYME
SG 1 records · 1 shown of 1
- 5 mg/5 mLinjectionNAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 5 mg/5 mLinjectionNAGLAZYME 1 mg/ml, solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|
| 5 mg/5 mL injection | Naglazyme 5mg/5ml solution for infusion vials | NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML | NAGLAZYME 1 mg/ml, solution à diluer pour perfusion | |||||
| 5 mg/5 mL liquid | NAGLAZYME | |||||||
| 1 mg per mL / per unit basis not stated cannot compare liquid | NAGLAZYME | |||||||
| 5 mg per mL / per unit basis not stated cannot compare injection | NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial | |||||||
unknown | NAGLAZYME | NAGLAZYME CONC SOLN FOR IV INFUSION 1MG/ML | NAGLAZYME |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in GB · SG · FR and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB · SG · FR que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB · SG · FR 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 GB · SG · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.